Acino (Group)

http://www.acino-pharma.com

Acino (SIX: ACIN), a Swiss-based pharmaceutical company, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino is a leader in advanced drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. As a partner of pharmaceutical companies worldwide, Acino supplies finished in-house developed products and/or provides customized one-stop solutions from product development and registration to contract manufacturing, packaging and logistics. Under the brand "Acino Switzerland", Acino markets Swiss-quality medicines in up and coming economies, currently 80 countries in the Middle East, Africa, Latin America and Asia. The Acino Group, headquartered in Aesch BL, has 788 employees and generated revenues of EUR 143 million in the first half-year 2013. *

	Start	2010-10-23 existent
	Industry	pharmaceutical
	Industry 2	drug delivery technology (drug formulation technology)

	Region	Basel BS
	Country	Switzerland
	Street	1 Erlenstr.
	City	4058 Basel BS
	Tel	+41-61-338-6000
		Address record changed: 2018-07-24

Basic data	Employees	E: 501 to 1,000 (2013-10-02)

		* Document for ï¿½About Sectionï¿½: Acino Holding AG. (10/2/13). "Press Release: Avista Capital Partners and Nordic Capital to Launch a Joint Public Tencer Offer to Acquire Acino. Offer Price of CHF 115.00 Represents a 33% Premium to the Closing Share Price on October 1, 2013". Aesch.

		Record changed: 2017-04-01

More documents for Acino (Group)

[1] Acino Holding AG. (10/2/13). "Press Release: Avista Capital Partners and Nordic Capital to Launch a Joint Public Tencer Offer to Acquire Acino. Offer Price of CHF 115.00 Represents a 33% Premium to the Closing Share Price on October 1, 2013". Aesch....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]